Author： Casey D.E.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 164-165
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Olanzapine in Schizophrenia and Affective Disorders
Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. :
Health economic considerations in the treatment of schizophrenia
By Souetre E.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Treatment Considerations in the Forensic Patient with Schizophrenia
Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. :
New treatments for movement disorders?
Trends in Pharmacological Sciences, Vol. 17, Iss. 10, 1996-10 ,pp. :